Financhill
Back

Enfusion 10K Form

Buy
54

ENFN
Enfusion

Last Price:
$11.11
Seasonality Move:
-19.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ENFN News And Ratings

See the #1 stock for the next 7 days that we like better than ENFN

ENFN Financial Statistics

Sales & Book Value

Annual Sales: $201.6M
Cash Flow: $7M
Price / Cash Flow: 55.76
Annual Sales: $0.77
Price / Book: 14.37

Profitability

EPS (TTM): 0.03000
Net Income (TTM): $2.8M
Gross Margin: $136.7M
Return on Equity: 3.17%
Return on Assets: 2.28%

Enfusion Earnings Forecast

Key Enfusion Financial Ratios

  • The Gross Profit Margin over the past 6 years for ENFN is 67.82%.
  • The Selling, General & Administrative Expenses for ENFN have been equal to 51.51% of Gross Profit Margin.
  • The Research & Development expenses have been 13.26% of Revenue.
  • The Net Earning history of ENFN is 1.40% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Enfusion Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Software
Sector: Information Technology
Current Symbol: ENFN
Website: enfusion.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.42
Quick Ratio: 3.16

Price-to-Earnings

Trailing P/E Ratio: 370
Forward P/E Ratio: 29.87

ENFN Technical Analysis vs Fundamental Analysis

Buy
54
Enfusion (ENFN) is a Buy

Is Enfusion a Buy or a Sell?

  • Enfusion stock is rated a Buy
    The current Enfusion [ENFN] share price is $11.10. The Score for ENFN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.